Patents by Inventor Jane Jourdan

Jane Jourdan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ISOLATING EXOSOMES
    Publication number: 20240226809
    Abstract: Described in certain example embodiments herein are methods of isolating exosomes from a biological fluid, such as those containing caseins.
    Type: Application
    Filed: February 23, 2022
    Publication date: July 11, 2024
    Applicant: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
    Inventors: Spencer MARSH, Kevin J. PRIDHAM, Linda Jane JOURDAN, Robert G. GOURDIE
  • METHODS OF ISOLATING EXOSOMES
    Publication number: 20240131473
    Abstract: Described in certain example embodiments herein are methods of isolating exosomes from a biological fluid, such as those containing caseins.
    Type: Application
    Filed: February 23, 2022
    Publication date: April 25, 2024
    Applicant: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
    Inventors: Spencer MARSH, Kevin J. PRIDHAM, Linda Jane JOURDAN, Robert G. GOURDIE
  • COMPOSITIONS AND METHODS OF TREATING A PI3K MEDIATED DISEASE
    Publication number: 20240075093
    Abstract: Described herein are compositions and formulations to treat and/or prevent a PI3K mediated disease or a symptom thereof in a subject in need thereof. In some embodiments, such compositions include engineered peptides capable of targeting PI3K or Connexin 43. Also described herein are methods of treating and/or preventing PI3K mediated disease or a symptom thereof. In some embodiments, the PI3K mediated disease is a cancer.
    Type: Application
    Filed: October 9, 2021
    Publication date: March 7, 2024
    Inventors: Robert G. Gourdie, Zhi Sheng, Kevin J. Pridham, Linda Jane Jourdan
  • ENGINEERED HEMICHANNELS, ENGINEERED VESICLES, AND USES THEREOF
    Publication number: 20210290539
    Abstract: Described herein are engineered hemichannels, engineered vesicles that can contain the one or more of the engineered hemichannels, pharmaceutical formulations thereof, and uses thereof. In some aspects, the engineered vesicles can include one or more cargo molecules. Also described herein are methods of loading the engineered vesicles. In some aspects, loading of one or more cargo molecules engineered vesicles can be optionally via an engineered hemichannel contained in the engineered vesicle.
    Type: Application
    Filed: July 30, 2019
    Publication date: September 23, 2021
    Inventors: Robert G. GOURDIE, L. JANE JOURDAN, Eda ROGERS
  • Alpha connexin c-terminal (ACT) peptides and methods of use thereof
    Patent number: 10398757
    Abstract: Provided herein are compositions and methods for use in promoting wound healing and tissue regeneration following tissue injury in a subject.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: September 3, 2019
    Assignee: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Gautam Ghatnekar, Robert Gourdie, Jane Jourdan
  • Alpha connexin C-terminal (ACT) peptides and methods of use thereof
    Patent number: 10398140
    Abstract: The present disclosure provides compositions and methods for treating or preventing macular degeneration in a subject. The disclosure also provides compositions and methods for preserving organs and tissues for transplantation, and for preventing cellular injury in organs or in subjects.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: September 3, 2019
    Assignee: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Gautam Ghatnekar, Robert Gourdie, Jane Jourdan
  • Methods of treating cancers with peptide-based modulators
    Patent number: 10092624
    Abstract: Provided are peptides that can inhibit collagen synthesis, processing and/or secretion. In some aspects, the therapeutic peptides may be used to treat a cancer such as, e.g., a pancreatic cancer or a glioblastoma.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: October 9, 2018
    Assignees: MUSC Foundation for Research Development, University of South Carolina
    Inventors: Robert G. Gourdie, Edie C. Goldsmith, L. Jane Jourdan, Joshua Matthew Rhett, Michael J. Yost
  • ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR USE IN TRANSPLANT
    Publication number: 20180077923
    Abstract: The present disclosure provides compositions and methods for treating or preventing macular degeneration in a subject. The disclosure also provides compositions and methods for preserving organs and tissues for transplantation, and for preventing cellular injury in organs or in subjects.
    Type: Application
    Filed: November 29, 2017
    Publication date: March 22, 2018
    Inventors: Gautam GHATNEKAR, Robert GOURDIE, Jane JOURDAN
  • COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION
    Publication number: 20180071363
    Abstract: Provided herein are compositions and methods for use in promoting wound healing and tissue regeneration following tissue injury in a subject.
    Type: Application
    Filed: November 29, 2017
    Publication date: March 15, 2018
    Inventors: Gautam GHATNEKAR, Robert GOURDIE, Jane JOURDAN
  • Compositions and methods for promoting wound healing and tissue regeneration
    Patent number: 9855313
    Abstract: Provided herein are compositions and methods for use in promoting wound healing and tissue regeneration following tissue injury in a subject.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: January 2, 2018
    Assignee: MUSC Foundation for Research Development
    Inventors: Gautam Ghatnekar, Robert Gourdie, Jane Jourdan
  • Alpha connexin C-terminal (ACT) peptides for use in transplant
    Patent number: 9844214
    Abstract: The present disclosure provides compositions and methods for treating or preventing macular degeneration in a subject. The disclosure also provides compositions and methods for preserving organs and tissues for transplantation, and for preventing cellular injury in organs or in subjects.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: December 19, 2017
    Assignee: MUSC Foundation for Research Development
    Inventors: Gautam Ghatnekar, Robert Gourdie, Jane Jourdan
  • ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR USE IN TRANSPLANT
    Publication number: 20170135334
    Abstract: The present disclosure provides compositions and methods for treating or preventing macular degeneration in a subject. The disclosure also provides compositions and methods for preserving organs and tissues for transplantation, and for preventing cellular injury in organs or in subjects.
    Type: Application
    Filed: June 28, 2016
    Publication date: May 18, 2017
    Inventors: Gautam GHATNEKAR, Robert GOURDIE, Jane JOURDAN
  • COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION
    Publication number: 20170128523
    Abstract: Provided herein are compositions and methods for use in promoting wound healing and tissue regeneration following tissue injury in a subject.
    Type: Application
    Filed: June 23, 2016
    Publication date: May 11, 2017
    Inventors: Gautam GHATNEKAR, Robert GOURDIE, Jane JOURDAN
  • COMPOSITIONS AND METHODS FOR WOUND HEALING AND TISSUE REPAIR
    Publication number: 20160287663
    Abstract: Provided are peptides that can inhibit collagen synthesis, processing and/or secretion from scar forming cells or fibroblasts. Also provided are methods for using the peptides to produce an anti-fibrotic, anti-scarring, anti-inflammatory, and/or pro-regenerative effect, e.g., on an injured or diseased tissue.
    Type: Application
    Filed: April 22, 2016
    Publication date: October 6, 2016
    Applicants: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT, UNIVERSITY OF SOUTH CAROLINA
    Inventors: Robert G. GOURDIE, Edie C. GOLDSMITH, L. Jane JOURDAN, Joshua Matthew RHETT, Michael J. YOST
  • Alpha Connexin c-Terminal (ACT) peptides for use in transplant
    Patent number: 9408381
    Abstract: The present disclosure provides compositions and methods for treating or preventing macular degeneration in a subject. The disclosure also provides compositions and methods for preserving organs and tissues for transplantation, and for preventing cellular injury in organs or in subjects.
    Type: Grant
    Filed: November 4, 2015
    Date of Patent: August 9, 2016
    Assignee: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Gautam Ghatnekar, Robert Gourdie, Jane Jourdan
  • Compositions and methods for promoting wound healing and tissue regeneration
    Patent number: 9394351
    Abstract: Provided herein are compositions and methods for use in promoting wound healing and tissue regeneration following tissue injury in a subject.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: July 19, 2016
    Assignee: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Gautam Ghatnekar, Robert Gourdie, Jane Jourdan
  • Peptide-based collagen modulators for wound healing and tissue repair
    Patent number: 9345744
    Abstract: Provided are peptides that can inhibit collagen synthesis, processing and/or secretion from scar forming cells or fibroblasts. Also provided are methods for using the peptides to produce an anti-fibrotic, anti-scarring, anti-inflammatory, and/or pro-regenerative effect, e.g., on an injured or diseased tissue.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: May 24, 2016
    Assignees: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT, UNIVERSITY OF SOUTH CAROLINA
    Inventors: Robert G. Gourdie, Edie C. Goldsmith, L. Jane Jourdan, Joshua Matthew Rhett, Michael J. Yost
  • ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR USE IN TRANSPLANT
    Publication number: 20160120171
    Abstract: The present disclosure provides compositions and methods for treating or preventing macular degeneration in a subject. The disclosure also provides compositions and methods for preserving organs and tissues for transplantation, and for preventing cellular injury in organs or in subjects.
    Type: Application
    Filed: November 4, 2015
    Publication date: May 5, 2016
    Inventors: Gautam GHATNEKAR, Robert GOURDIE, Jane JOURDAN
  • COMPOSITIONS AND METHODS FOR WOUND HEALING AND TISSUE REPAIR
    Publication number: 20150174196
    Abstract: Provided are peptides that can inhibit collagen synthesis, processing and/or secretion from scar forming cells or fibroblasts. Also provided are methods for using the peptides to produce an anti-fibrotic, anti-scarring, anti-inflammatory, and/or pro-regenerative effect, e.g., on an injured or diseased tissue.
    Type: Application
    Filed: April 25, 2013
    Publication date: June 25, 2015
    Applicants: UNIVERSITY OF SOUTH CAROLINA, MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Robert G. Gourdie, Edie C. Goldsmith, L. Jane Jourdan, Joshua Matthew Rhett, Michael J. Yost
  • Compositions and methods for promoting wound healing and tissue regeneration
    Patent number: 8357668
    Abstract: Provided herein are compositions and methods for use in promoting wound healing and tissue regeneration following tissue injury in a subject.
    Type: Grant
    Filed: August 30, 2010
    Date of Patent: January 22, 2013
    Assignee: Musc Foundation for Research Development
    Inventors: Robert Gourdie, Gautam Ghatnekar, Jane Jourdan